Dogs with histologically confirmed lymphoma were treated with a 14-week induction chemotherapy protocol that included dexamethasone. A phase II clinical trial was done using a standard two-stage design. Complete remission occurred in 21 (88%) dogs, with a median initial progression-free interval of 186 days. Toxicity was mild and self-limiting in the majority of dogs.
|Original language||English (US)|
|Number of pages||6|
|Journal||Journal of the American Animal Hospital Association|
|State||Published - Jan 1 2007|